Mengis Capital Management »

Vertex Pharmaceuticals Incorporated shares owned by Mengis Capital Management

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Mengis Capital Management from 13F filings

Historical chart of Mengis Capital Management investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Mengis Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Mengis Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $227k 500 453.36
2025-06-30 $223k 500 445.20

More positions owned by Mengis Capital Management

Apple (AAPL)
Microsoft Corporation (MSFT)
Alphabet Inc Class C cs (GOOG)
JPMorgan Chase & Co. (JPM)
Chevron Corporation (CVX)
Gs Intl Dvlpd Etf FD (GSIE)
Deere & Company (DE)
Paccar (PCAR)
Qualcomm (QCOM)
Quanta Services (PWR)
Eli Lilly & Co. (LLY)
Amazon (AMZN)
Novartis (NVS)
Costco Wholesale Corporation (COST)
Medtronic (MDT)

View all positions for Mengis Capital Management

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
State Street Corporation
Geode Capital Management
Capital Research and Management Company - Division 3
Alliancebernstein
Loomis, Sayles and
Wellington Management Company
Victory Capital Management
Jennison Associates
Norges Bank Investment Management
Ubs Global Asset Management Americas
ClearBridge Advisors

View all funds holding Vertex Pharmaceuticals Incorporated